Skip to content

Nasal high-flow oxygen therapy in critically ill patients

Nasal high-flow oxygen therapy in critically ill patients - Nasal high-flow oxygen therapy in critically ill patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000024179
Enrollment
300
Registered
2016-10-01
Start date
2016-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory failure in critically ill patients

Interventions

None listed

Sponsors

Tohoku University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Critically ill patients received nasal high-flow oxygen therapy for respiratory failure

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
ICU stay

Secondary

MeasureTime frame
ICU Mortality 90-day Mortality

Countries

Japan

Contacts

Public ContactShigekazu Sugino

Tohoku University Department of Anesthesiology and Perioperative Medicine

sugino@ruby.ocn.ne.jp0227177321

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026